Basics Sonoma Pharmaceuticals, Inc. Sonoma Pharmaceuticals Inc is engaged in developing and commercializing differentiated therapies to patients living with chronic skin conditions. It develops solutions in to treat skin conditions, such as acne, atopic dermatitis, and scarring. IPO Date: February 1, 2007 Sector: Healthcare Industry: Pharma Market Cap: $5.14M Activated in VL: True Average Daily Range Avg Daily Range: $0.14 | 3.63% Avg Daily Range (30 D): $0.10 | 3.04% Avg Daily Range (90 D): $0.12 | 4.28% Institutional Daily Volume Avg Daily Volume: .59M Avg Daily Volume (30 D): 1.84M Avg Daily Volume (90 D): 1.58M Trade Size Avg Trade Size (Sh.): 273 Avg Trade Size (Sh.) (30 D): 139 Avg Trade Size (Sh.) (90 D): 154 Institutional Trades Total Inst.Trades: 15 Avg Inst. Trade: $.97M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: K     News Jul 12, 2024 @ 9:35 AM Why Ericsson Shares Are Trading Higher; Here Are 2... Source: Avi Kapoor Jun 28, 2024 @ 12:50 PM Sonoma Pharmaceuticals (SNOA) Shows Fast-paced Mom... Source: Zacks Equity Research Jan 24, 2024 @ 1:14 PM Why Netflix Shares Are Trading Higher By 10%; Here... Source: Avi Kapoor Dec 18, 2023 @ 6:05 PM Why Lantheus Holdings Shares Are Trading Lower By ... Source: Avi Kapoor Dec 18, 2023 @ 1:10 PM Why Arcutis Biotherapeutics Shares Are Trading Hig... Source: Avi Kapoor Financials   TTM Q3 2025 Q2 2025 Basic EPS $7.81 $-.63 $-.59 Diluted EPS $7.81 $-.63 $-.59 Revenue $ 13.97M $ 3.56M $ 3.58M Gross Profit $ 5.03M $ 1.27M $ 1.36M Net Income / Loss $ -3.84M $ -.93M $ -.61M Operating Income / Loss $ -4.46M $ -1.03M $ -.85M Cost of Revenue $ 8.95M $ 2.29M $ 2.22M Net Cash Flow $ 2.83M $ 1.16M $ 1.49M PE Ratio 0.45     Splits Aug 30, 2024:   1:20 Jun 20, 2019:   1:9 Jun 27, 2016:   1:5 Apr 01, 2013:   1:7